Showing 301-310 of 1093 results for "".
MATV News: Revance RT002 Positive Results; RealSelf Trends Report; Jawline Aesthetics
https://modernaesthetics.com/series/matv-news/matv-news-revance-rt002-positive-results-realself-trends-report-jawline-aesthetics/33463/Revance Therapeutics RT002 delivered positive top-line results in alleviating moderate to severe glabellar lines, social media presence may matter more than experience in patient Google searches, and RealSelf reveals the latest annual trends in cosmetic treatments. Plus, the ASPS names Steven WilliaMATV News: Patient Satisfaction Factors; 2018 AES Update; Spotlyte Launch
https://modernaesthetics.com/series/matv-news/matv-news-patient-satisfaction-factors-2018-aes-update-spotlyte-launch/33260/New research examines what influences patient satisfaction most following plastic surgery, update from the 2018 Aesthetic Extender Symposium, Thermi launches Arvati, and Allergan debuts thespotlyte.com for consumer education on aesthetic medicine. Plus, what do the new guidelines for treatment teensMATV News: Brazilian Butt Lift Advisory; Patient Engagement Report; More
https://modernaesthetics.com/series/matv-news/matv-news-brazilian-butt-lift-advisory-patient-engagement-report-more/33261/Multi-Society Task Force for Safety in Gluteal Fat Grafting releases a practice advisory, the FDA cracks down on vaginal rejuvenation claims, Evolus resubmits BLA for DWP-450, and eRelevance shares results of new patient engagement report. Plus, is “SnapChat Dysmorphia” creating unrealistic expectatMATV News: RealSelf Worth It Ratings; Cutera and Candela Launches; FDA Approves Qbrexza
https://modernaesthetics.com/series/matv-news/matv-news-realself-worth-it-ratings-cutera-and-candela-launches-fda-approves-qbrexza/33264/Demand for fat reduction and interest in vaginal rejuvenation at all-time high, RealSelf reports, Cutera and Candela both launch new devices, and there's a new FDA-approved treatment for hyperhidrosis. Plus, find out how the first #RealDealAesthetics Twitter Chat went, and share your thoughts on choMATV News: Restylane Lyft for Hands; Positive Results for ThermiVa; Rosacea Burden
https://modernaesthetics.com/series/matv-news/matv-news-restylane-lyft-for-hands-positive-results-for-thermiva-rosacea-burden/33270/Restylane Lyft is now approved to fill the dorsal hands, #WeAllGrow Latina Network in favor of body contouring procedures, a new study on ThermiVa shows positive results, and Galderma shares results of global survey on rosacea showing need for physicians to open a dialogue with patients suffering frMATV News: ASAPS Stats; Facial Rejuvenation Meeting Highlights; Millennials and Aesthetics; Tattoo Removal Misperceptions
https://modernaesthetics.com/series/matv-news/matv-news-asaps-stats-facial-rejuvenation-meeting-highlights-millennials-and-aesthetics-tattoo-removal-misperceptions/33277/New data from the American Society for Aesthetic Plastic Surgery show surgical procedures are still very much in demand, this year's American Academy of Facial Plastic and Reconstructive Surgery Facial Rejuvenation Meeting highlighted the latest improvements in aesthetic medicine and reconstructiveMATV News: ASPS News; Botox Biosimilar; CareCredit Enters MedSpa Market; Medical Spa Show Update
https://modernaesthetics.com/series/matv-news/matv-news-asps-news-botox-biosimilar-credit-credit-enters-medspa-market-medical-spa-show-update/33284/Plastic Surgery is on the rise, according to new stats from the American Society of Plastic Surgeons, Mylan and Revance are partnering to develop and market a Botox biosimilar, CareCredit is expanding into the day and medical spa markets. Also, a recap of the America Med Spa Association's first everMATV News: Scar Wars; New CoolSculpting Campaign Focuses on Men; AAFPRS Trends
https://modernaesthetics.com/series/matv-news/matv-news-scar-wars-new-coolsculpting-campaign-focuses-on-men-aafprs-trends/33290/New research shows the importance of developing scar measures that balance perceptions of patients and physicians, CoolSculpting launches new "Not Cool vs. Cool" campaign with a focus on men, and a look at the results of the annual survey of the American Academy of Facial Plastic and ReconstructiveMATV News: RT002 Phase 3 Results; Expanded Indication for CoolSculpting; Safer Gluteal Fat Grafting
https://modernaesthetics.com/series/matv-news/matv-news-rt002-phase-3-results-expanded-indication-for-coolsculpting-safer-gluteal-fat-grafting/33293/The Describe PFD Patch is now FDA cleared for all commonly used lasers for tattoo removal, RT002 delivers positive top-line results in alleviating moderate-to-severe glabellar lines in Phase 3 trials with duration of effect up to 6 months, and new recommendations are released by ASERF's Gluteal FatMATV News: The Art of Injecting; Chemicals in Beauty Products; Neurotoxin Pipeline
https://modernaesthetics.com/series/matv-news/matv-news-the-art-of-injecting-chemicals-in-beauty-products-neruotoxin-pipeline/33322/A highly detailed body painting project is helping physicians better improve botulinum toxin injection techniques, a new study shows women with skin of color have higher levels of beauty-product related chemicals in their bodies, and a neuromodulator in the pipeline is showing promise. And, a look a